Bioidentical 'Natural' Hormone Evaluation in Early Menopause
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Prospective double blind pilot study comparing bioidentical 'natural' hormones to low-dose
PremPro. Forty participants will be enrolled. The purpose of this study is to try to gather
early information about safety when "natural" or bioidentical hormones are used during early
menopause.
Phase:
Phase 2
Details
Lead Sponsor:
Jeanne Drisko, MD, CNS, FACN
Collaborators:
Private Foundation through KU Endowment University of Kansas